Synthesis of 3-Aminochroman Derivatives by Radical Cyclization

Organic Letters

Volumn 5, Issue 23, 2003, Pages 4253-4256

  Pavé, Grégoire ^a   Usse Versluys, Stéphanie ^a   Viaud Massuard, Marie Claude ^b   Guillaumet, Gérald ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b EA 3247   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETYL 3 AMINO 3,4 DIHYDRO 2H 1 BENZOPYRAN; BENZOPYRAN DERIVATIVE; BETA CYCLODEXTRIN; CHROMAN DERIVATIVE; DEXTRO SERINE; METHYL 3 AMINO 3,4 DIHYDRO 2H 1 BENZOPYRAN 5 CARBOXYLATE; PYRAN DERIVATIVE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHIRALITY; CYCLIZATION; DRUG SYNTHESIS; ENANTIOMER; PURIFICATION;

EID: 0344496880     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0353215     Document Type: Article

References (31)

1. (a) Baumgarten, H. G.; Göthert, M. Serotoninergic Neurons and 5-HAT Receptors in the CNS; Springer-Verlag: Berlin, 1997; Vol. 129.
2. (b) Martin, G. R.; Eglen, R. M.; Hoyer, D.; Hamblin, M. W.; Yocca, F. Annals of the New York Academy of Sciences; New York Academy of Sciences: New York, 1998; Vol. 861.
3. (a) Alessandri, B.; Tsuchida, E.; Bullock, R. M. Brain Res. 1999, 845, 232.
4. (b) Kamei, K.; Maeda, N.; Ogino, R.; Koyama, M.; Nakajima, M.; Tatsuoka, T.; Ohno, T. Inoue, T. Bioorg. Med. Chem. Lett. 2001, 11, 595.
5. (c) Harkany, T.; Mulder, J.; Horvath, K. M.; Keijser, J.; van der Meerberg, E. K.; Nyakas, C.; Luiten, P. G. M. Neuroscience 2001, 108, 629.
6. (a) Olivier, B.; van Wijngaarden, I.; Soudjin, W. Serotonin Receptors and their Ligands; Elsevier: Amsterdam, 1997.
7. (b) Olivier, B.; van Wijngaarden, I. Prog. Drug. Res. 1999, 52, 103.
8. (c) López-Rodriguez, M. L.; Ayala, D.; Benhamú, B.; Morcillo, M. J.; Viso, A. Curr. Med. Chem. 2002, 9, 443.
9. Hoyer, D.; Hannon, J. P.; Martin, G. R. Pharmacol. Biochem. Behav. 2002, 71, 533.
10. (a) Bard, J. A.; Zgombick, J.; Adham, N.; Vaysee, P.; Branchek, T. A.; Weinshank, R. L. J. Biol. Chem. 1993, 268, 23422. Ruat, M.; Traiffort, E.; Leurs, R.; Tardivel-Lacombe, J.; Diaz, J.; Arrang, J.-M.; Schwartz, J. C. Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 8547.
11. (a) Bard, J. A.; Zgombick, J.; Adham, N.; Vaysee, P.; Branchek, T. A.; Weinshank, R. L. J. Biol. Chem. 1993, 268, 23422. Ruat, M.; Traiffort, E.; Leurs, R.; Tardivel-Lacombe, J.; Diaz, J.; Arrang, J.-M.; Schwartz, J. C. Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 8547.
12. (c) To, Z. P.; Bonhaus, D. W.; Eglen, R. M.; Jakeman, L. B. Br. J. Pharm. 1995, 115, 107.
13. (d) Shen, Y.; Monsma, F. J.; Metcalf, M. A.; Jose, P. A.; Hamblin, M. W. ; Sibley, D. R. J. Biol. Chem. 1993, 268, 18200.
14. Lovenberg, T. W.; Baron, B. M.; deLecea, L.; Miller, J. O.; Prosser, R. A.; Rea, M. A.; Foye, P. E.; Rucke, M.; Slone, A. L.; Siegel, B. W.; Danielson, P. E.; Sutcliffe, J. G.; Erlander, M. G. Neuron 1993, 11, 449.
15. (a) Podona, T.; Guardiola-Lemaître, B.; Caignard, D. H.; Adam, G.; Pfeiffer, B.; Renard, P.; Guillaumet, G. J. Med. Chem. 1994, 37, 1779.
16. (b) Comoy, C.; Marot, C.; Podona, T.; Baudin, M. L.; Morin-Allory, L.; Guillaumet, G.; Pfeiffer, B.; Caignard, D. H.; Renard, P.; Rettori, M. C.; Adam, G.; Guardiola-Lemaître, B. J. Med. Chem. 1996, 39, 4285.
17. (c) Rezaie, R.; Joseph, B.; Bremner, J. B.; Delagrange, P.; Kopp, C.; Misslin, R.; Pfeiffer, B.; Renard, P.; Guillaumet, G. J. Pharm. Pharmacol. 2001, 53, 959-968.
18. (d) Usse, S.; Guillaumet, G.; Viaud, M. C. J. Org. Chem. 2000, 65, 914.
19. (e) Usse, S.; Pavé, G.; Guillaumet, G.; Viaud-Massuard, M.-C. Tetrahedron: Asymmetry 2001, 12, 1689.
20. (f) Pavé, G.; Léger, J.-M.; Jarry, C.; Viaud-Massuard, M.-C.; Guillaumet, G. J. Org. Chem. 2003, 68, 1401.
21. Hammarberg, E.; Nordvall, G.; Leideborg, R.; Nylöf, M.; Hanson, S.; Johansson, L.; Thorberg, S.-O.; Tolf, B.-O.; Jerning, E.; Svantesson, G. T.; Mohell, N.; Ahlgren, C.; Westlind-Danielsson, A.; Csöregh, I.; Johansson, R. J. Med. Chem. 2000, 43, 2837.
22. Dupau, P.; Le Gendre, P.; Bruneau, C.; Dixneuf, P. H. Synlett 1999, 11, 1832.
23. Dupau, P.; Bruneau, C.; Dixneuf, P. H. Tetrahedron: Asymmetry 1999, 10, 3467.
24. See Supporting Information and also: (a) Garner, P.; Park, J. M. Org. Synth. 1992, 70, 18. (b) Dondoni, A.; Perrone, D. Synthesis 1997, 5, 527.
25. See Supporting Information and also: (a) Garner, P.; Park, J. M. Org. Synth. 1992, 70, 18. (b) Dondoni, A.; Perrone, D. Synthesis 1997, 5, 527.
26. Curran, D. P. In Comprehensive Organic Synthesis; Pergamon Press: Elmsford, NY, 1991; Vol. 4, pp 715-831.
27. Garegg, P. J.; Samuelsson, B. J. Chem. Soc., Chem. Commun. 1979, 979.
28. Zard, S. Z. Angew. Chem., Int. Ed. Engl. 1997, 36, 672.
29. Ishibashi, H.; Matsukida, H.; Toyao, A.; Tamura, O.; Takeda, Y. Synlett 2000, 10, 1497.
30. Ikeda, M.; Hamada, M.; Yamashita, T.; Matsui, K.; Sato, T.; Ishibashi, H. J. Chem. Soc., Perkin Trans. 1 1999, 1949.
31. Enantiomeric excess was determined by comparison of each enantiomer with a racemic mixture of the corresponding amine.